2m 2m 2m 2m 2m 2m 2m
Co-Diagnostics (CODX)
NASDAQ
$5.02-$1.20 (-19.36%)
Price as of Jun 03, 2026 6:49 PM EDT- $31.2MMarket Cap
- -26.92%1-Year Change
- Medical DevicesIndustry
Co-Diagnostics (CODX)
$5.02-$1.20 (-19.36%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 683,365 -58.35% | 1.6M -81.88% | 9.1M -73.54% | 34.2M -65.04% | |
Cost of Revenue | 222,377 -77.74% | 999,124 -76.13% | 4.2M -23.65% | 5.5M -52.65% | |
Gross Profit | 400,112 -86.28% | 2.9M +11.00% | 2.6M -90.86% | 28.7M -66.71% | |
Sales and Marketing Expense | 2.4M -46.89% | 4.5M -34.65% | 6.9M -6.59% | 7.3M -45.18% | |
Research and Development Expense | -19.1M -8.78% | -21.0M -8.64% | -23.0M +31.68% | -17.4M +16.55% | |
Depreciation and Amortization Expense | 1.1M -19.64% | 1.4M +11.93% | 1.2M -4.07% | 1.3M +282.49% | |
Total Operating Expenses | 50.6M +17.60% | 43.0M -5.15% | 45.3M -18.64% | 55.7M +38.44% | |
Operating Profit | -50.2M +25.16% | -40.1M -6.15% | -42.7M +58.29% | -27.0M -158.57% | |
Interest Income | 292,932 -73.17% | 1.1M -6.03% | 1.2M +65.03% | 704,044 +1,442.91% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 292,932 -73.17% | 1.1M -6.03% | 1.2M +65.03% | 704,044 +1,442.91% | |
Total Nonoperating Income and Expense | 1.7M -33.85% | 2.5M -45.61% | 4.6M -43.49% | 8.1M +1,995.02% | |
Income before Taxes | -48.5M +29.08% | -37.6M -1.39% | -38.1M +102.21% | -18.8M -141.30% | |
Income Taxes | -1.6M -2,916.86% | 57,368 +102.07% | -2.8M -39.73% | -4.6M -151.34% | |
Extraordinary Items | 18.9M N/A | N/A N/A | 0 -100.00% | 15.4M N/A | |
Net Income | -47.3M +26.62% | -37.4M +5.76% | -35.3M +148.15% | -14.2M -138.84% | |
Net Income from Continuing Operations Applicable to Common | -48.5M +29.08% | -37.6M -1.39% | -38.1M +102.21% | -18.8M -141.30% | |
Basic EPS and Net Income | -35.25 +2,742.74% | -1.24 +3.33% | -1.20 +166.67% | -0.45 -135.43% | |
Diluted EPS and Net Income | -35.25 +2,742.74% | -1.24 +3.33% | -1.20 +166.67% | -0.45 -136.59% | |
Basic Weighted Average Shares | 1.3M -95.62% | 30.3M +3.37% | 29.3M -6.77% | 31.5M +9.02% | |
Diluted Weighted Average Shares | 1.3M -95.62% | 30.3M +3.37% | 29.3M -6.77% | 31.5M +5.27% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 11.9M +304.71% | 2.9M -80.31% | 14.9M -35.07% | 23.0M -74.07% | |
Short-Term Investments | N/A N/A | 26.8M -38.55% | 43.6M -25.15% | 58.3M +4,543.56% | |
Cash and Cash Equivalents and Short-Term Investments | 11.9M -60.05% | 29.7M -49.19% | 58.5M -27.95% | 81.3M -9.57% | |
Total Current Assets | 13.7M -57.59% | 32.3M -48.03% | 62.1M -32.99% | 92.7M -19.45% | |
Accumulated Depreciation | 3.9M +19.16% | 3.3M +46.96% | 2.2M +62.69% | 1.4M +120.56% | |
Property and Plant and Equipment and Net | 2.3M -17.72% | 2.8M -9.04% | 3.0M +19.54% | 2.5M +31.36% | |
Total Long-Term Assets | 2.3M -17.72% | 2.8M -9.04% | 3.0M +19.54% | 2.5M +31.36% | |
Total Assets | 24.7M -61.34% | 64.0M -32.86% | 95.3M -22.56% | 123.1M -23.09% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 2.4M -74.39% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.5M -51.62% | 7.3M +27.28% | 5.7M +48.38% | 3.9M -69.25% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 574,301 -75.79% | 2.4M -33.35% | 3.6M -24.15% | 4.7M -63.79% | |
Total Liabilities | 4.1M -57.54% | 9.7M +4.09% | 9.3M +8.65% | 8.6M -66.48% | |
Retained Earnings | -80.4M +143.26% | -33.0M -818.57% | 4.6M -88.48% | 39.9M -26.28% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 86.0M -24.89% | 114.5M -14.84% | |
Total Shares Outstanding | 2.1M -93.66% | 33.1M +5.74% | 31.3M +1.25% | 30.9M -8.71% | |
Cash Flow | |||||
Cash from Operating Activities | -29.1M -0.06% | -29.2M +32.03% | -22.1M -436.17% | 6.6M -84.01% | |
Capital Expenditures | 700,047 -6.45% | 748,352 -45.19% | 1.4M -4.36% | 1.4M +113.23% | |
Cash from Investing Activities | 26.3M +53.91% | 17.1M +10.93% | 15.4M +126.46% | -58.2M -1,519.19% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.8M +11,266.69% | 103,914 +107.62% | -1.4M -90.28% | -14.0M -3,215.91% | |
Financials Ratio | |||||
Gross Margin | 67.46% +72.50% | 39.11% -27.29% | 53.78% -35.96% | 83.98% -4.76% | |
Operating Margin | -7,340.93% +200.51% | -2,442.80% +417.95% | -471.63% +498.16% | -78.85% -267.54% | |
Return on Assets | -106.63% +127.32% | -46.91% +44.98% | -32.36% +221.68% | -10.06% -131.73% | |
Return on Equity | N/A N/A | N/A N/A | -35.24% +208.12% | -11.44% -131.38% | |
Revenue Growth | -58.35% -28.74% | -81.88% +11.34% | -73.54% +13.06% | -65.04% -307.82% | |
Current Ratio | 3.87 -12.36% | 4.41 -59.17% | 10.81 -54.84% | 23.94 +161.99% | |
Cash Ratio | 3.36 +736.47% | 0.40 -84.53% | 2.60 -56.24% | 5.93 -15.68% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow